In patients with advanced hepatocellular carcinoma receiving palliative chemotherapy, the “TT” genotype predicted a favorable treatment outcome.12,13 The product of GALNT14 gene was a catalytic enzyme that catalyzed O-glycosylation of many proteins including the death receptor (DR)-4 and -5. Here, GALNT14 is linked to hepatocellular carcinoma.